nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorpromazine—ALB—Acetylsalicylic acid—Kawasaki disease	0.415	0.657	CbGbCtD
Chlorpromazine—ABCB1—Acetylsalicylic acid—Kawasaki disease	0.217	0.343	CbGbCtD
Chlorpromazine—KCNH2—endocardium—Kawasaki disease	0.068	0.199	CbGeAlD
Chlorpromazine—DRD4—heart—Kawasaki disease	0.0128	0.0376	CbGeAlD
Chlorpromazine—SMPD1—heart—Kawasaki disease	0.0114	0.0334	CbGeAlD
Chlorpromazine—CALM2—artery—Kawasaki disease	0.0113	0.033	CbGeAlD
Chlorpromazine—CALM1—artery—Kawasaki disease	0.0112	0.0329	CbGeAlD
Chlorpromazine—SMPD1—skin of body—Kawasaki disease	0.0112	0.0327	CbGeAlD
Chlorpromazine—HTR7—artery—Kawasaki disease	0.0109	0.0321	CbGeAlD
Chlorpromazine—ALB—gall bladder—Kawasaki disease	0.00973	0.0285	CbGeAlD
Chlorpromazine—CALM2—endothelium—Kawasaki disease	0.00951	0.0279	CbGeAlD
Chlorpromazine—CALM1—endothelium—Kawasaki disease	0.00947	0.0278	CbGeAlD
Chlorpromazine—HTR7—endothelium—Kawasaki disease	0.00925	0.0271	CbGeAlD
Chlorpromazine—CALM2—gall bladder—Kawasaki disease	0.00825	0.0242	CbGeAlD
Chlorpromazine—CALM3—cardiac ventricle—Kawasaki disease	0.00804	0.0236	CbGeAlD
Chlorpromazine—CALM3—myocardium—Kawasaki disease	0.00756	0.0222	CbGeAlD
Chlorpromazine—HTR2A—artery—Kawasaki disease	0.00683	0.02	CbGeAlD
Chlorpromazine—CALM2—cardiac ventricle—Kawasaki disease	0.00632	0.0185	CbGeAlD
Chlorpromazine—CALM1—cardiac ventricle—Kawasaki disease	0.00629	0.0184	CbGeAlD
Chlorpromazine—CALM2—neck—Kawasaki disease	0.00627	0.0184	CbGeAlD
Chlorpromazine—CALM1—neck—Kawasaki disease	0.00625	0.0183	CbGeAlD
Chlorpromazine—HTR7—neck—Kawasaki disease	0.0061	0.0179	CbGeAlD
Chlorpromazine—CALM2—myocardium—Kawasaki disease	0.00594	0.0174	CbGeAlD
Chlorpromazine—CALM1—myocardium—Kawasaki disease	0.00591	0.0173	CbGeAlD
Chlorpromazine—HTR2A—endothelium—Kawasaki disease	0.00577	0.0169	CbGeAlD
Chlorpromazine—KCNH2—cardiac ventricle—Kawasaki disease	0.00572	0.0168	CbGeAlD
Chlorpromazine—KCNH2—myocardium—Kawasaki disease	0.00538	0.0158	CbGeAlD
Chlorpromazine—CALM3—heart—Kawasaki disease	0.00528	0.0155	CbGeAlD
Chlorpromazine—BCHE—cardiac ventricle—Kawasaki disease	0.00527	0.0154	CbGeAlD
Chlorpromazine—CHRM2—heart—Kawasaki disease	0.0052	0.0152	CbGeAlD
Chlorpromazine—ALB—heart—Kawasaki disease	0.00489	0.0143	CbGeAlD
Chlorpromazine—HTR2B—heart—Kawasaki disease	0.00471	0.0138	CbGeAlD
Chlorpromazine—HTR2B—skin of body—Kawasaki disease	0.00461	0.0135	CbGeAlD
Chlorpromazine—CALM2—heart—Kawasaki disease	0.00415	0.0122	CbGeAlD
Chlorpromazine—CALM1—heart—Kawasaki disease	0.00413	0.0121	CbGeAlD
Chlorpromazine—CALM2—skin of body—Kawasaki disease	0.00406	0.0119	CbGeAlD
Chlorpromazine—CALM1—skin of body—Kawasaki disease	0.00404	0.0119	CbGeAlD
Chlorpromazine—HTR7—heart—Kawasaki disease	0.00403	0.0118	CbGeAlD
Chlorpromazine—ADRA1A—heart—Kawasaki disease	0.00389	0.0114	CbGeAlD
Chlorpromazine—HTR2A—neck—Kawasaki disease	0.0038	0.0112	CbGeAlD
Chlorpromazine—KCNH2—heart—Kawasaki disease	0.00376	0.011	CbGeAlD
Chlorpromazine—BCHE—heart—Kawasaki disease	0.00346	0.0101	CbGeAlD
Chlorpromazine—BCHE—skin of body—Kawasaki disease	0.00339	0.00993	CbGeAlD
Chlorpromazine—ADRA2A—heart—Kawasaki disease	0.00296	0.00867	CbGeAlD
Chlorpromazine—HTR2A—heart—Kawasaki disease	0.00251	0.00737	CbGeAlD
Chlorpromazine—ABCB1—heart—Kawasaki disease	0.00165	0.00483	CbGeAlD
Chlorpromazine—HTR2B—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	0.000101	0.00375	CbGpPWpGaD
Chlorpromazine—SLC22A1—Metabolism—ITPKC—Kawasaki disease	9.69e-05	0.0036	CbGpPWpGaD
Chlorpromazine—KCNH2—SIDS Susceptibility Pathways—VEGFA—Kawasaki disease	9.59e-05	0.00356	CbGpPWpGaD
Chlorpromazine—DRD1—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	9.53e-05	0.00354	CbGpPWpGaD
Chlorpromazine—HTR6—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	9.48e-05	0.00352	CbGpPWpGaD
Chlorpromazine—CALM1—Endochondral Ossification—MMP9—Kawasaki disease	9.48e-05	0.00352	CbGpPWpGaD
Chlorpromazine—CALM2—Endochondral Ossification—MMP9—Kawasaki disease	9.48e-05	0.00352	CbGpPWpGaD
Chlorpromazine—HTR7—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	9.47e-05	0.00352	CbGpPWpGaD
Chlorpromazine—DRD3—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	9.4e-05	0.00349	CbGpPWpGaD
Chlorpromazine—DRD5—GPCR ligand binding—CCR5—Kawasaki disease	9.36e-05	0.00347	CbGpPWpGaD
Chlorpromazine—DRD4—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	9.07e-05	0.00337	CbGpPWpGaD
Chlorpromazine—CHRM3—Metabolism—ITPKC—Kawasaki disease	8.95e-05	0.00332	CbGpPWpGaD
Chlorpromazine—HTR1A—G alpha (i) signalling events—CCR5—Kawasaki disease	8.83e-05	0.00328	CbGpPWpGaD
Chlorpromazine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	8.66e-05	0.00321	CbGpPWpGaD
Chlorpromazine—CALM1—Endochondral Ossification—VEGFA—Kawasaki disease	8.51e-05	0.00316	CbGpPWpGaD
Chlorpromazine—CALM2—Endochondral Ossification—VEGFA—Kawasaki disease	8.51e-05	0.00316	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—Kawasaki disease	8.38e-05	0.00311	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—ITPKC—Kawasaki disease	8.21e-05	0.00305	CbGpPWpGaD
Chlorpromazine—HTR1A—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	8.19e-05	0.00304	CbGpPWpGaD
Chlorpromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	8.16e-05	0.00303	CbGpPWpGaD
Chlorpromazine—HTR2C—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	8.15e-05	0.00303	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—Kawasaki disease	8.11e-05	0.00301	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—Kawasaki disease	8.11e-05	0.00301	CbGpPWpGaD
Chlorpromazine—DRD3—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	8.06e-05	0.00299	CbGpPWpGaD
Chlorpromazine—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	7.8e-05	0.0029	CbGpPWpGaD
Chlorpromazine—DRD2—G alpha (i) signalling events—CCR5—Kawasaki disease	7.75e-05	0.00288	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—ITPKC—Kawasaki disease	7.54e-05	0.0028	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—ITPKC—Kawasaki disease	7.49e-05	0.00278	CbGpPWpGaD
Chlorpromazine—CHRM2—G alpha (i) signalling events—CCR5—Kawasaki disease	7.49e-05	0.00278	CbGpPWpGaD
Chlorpromazine—CALM3—Platelet degranulation—VEGFA—Kawasaki disease	7.36e-05	0.00273	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—ITPKC—Kawasaki disease	7.25e-05	0.00269	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—ITPKC—Kawasaki disease	7.25e-05	0.00269	CbGpPWpGaD
Chlorpromazine—HTR6—GPCR ligand binding—CCR5—Kawasaki disease	7.22e-05	0.00268	CbGpPWpGaD
Chlorpromazine—HTR7—GPCR ligand binding—CCR5—Kawasaki disease	7.21e-05	0.00268	CbGpPWpGaD
Chlorpromazine—DRD2—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	7.19e-05	0.00267	CbGpPWpGaD
Chlorpromazine—CALM2—Platelet degranulation—VEGFA—Kawasaki disease	7.12e-05	0.00264	CbGpPWpGaD
Chlorpromazine—CALM1—Platelet degranulation—VEGFA—Kawasaki disease	7.12e-05	0.00264	CbGpPWpGaD
Chlorpromazine—HTR2A—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	7.08e-05	0.00263	CbGpPWpGaD
Chlorpromazine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	7.06e-05	0.00262	CbGpPWpGaD
Chlorpromazine—CHRM1—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	7.04e-05	0.00261	CbGpPWpGaD
Chlorpromazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	7.02e-05	0.00261	CbGpPWpGaD
Chlorpromazine—CHRM3—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	7.02e-05	0.00261	CbGpPWpGaD
Chlorpromazine—CALM3—Response to elevated platelet cytosolic Ca2+—VEGFA—Kawasaki disease	7.01e-05	0.0026	CbGpPWpGaD
Chlorpromazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	6.98e-05	0.00259	CbGpPWpGaD
Chlorpromazine—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	6.95e-05	0.00258	CbGpPWpGaD
Chlorpromazine—ADRA2A—G alpha (i) signalling events—CCR5—Kawasaki disease	6.94e-05	0.00258	CbGpPWpGaD
Chlorpromazine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—Kawasaki disease	6.94e-05	0.00258	CbGpPWpGaD
Chlorpromazine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	6.93e-05	0.00257	CbGpPWpGaD
Chlorpromazine—DRD4—GPCR ligand binding—CCR5—Kawasaki disease	6.91e-05	0.00256	CbGpPWpGaD
Chlorpromazine—HRH4—GPCR downstream signaling—CCR5—Kawasaki disease	6.86e-05	0.00255	CbGpPWpGaD
Chlorpromazine—CALM1—Response to elevated platelet cytosolic Ca2+—VEGFA—Kawasaki disease	6.79e-05	0.00252	CbGpPWpGaD
Chlorpromazine—CALM2—Response to elevated platelet cytosolic Ca2+—VEGFA—Kawasaki disease	6.79e-05	0.00252	CbGpPWpGaD
Chlorpromazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	6.69e-05	0.00248	CbGpPWpGaD
Chlorpromazine—HTR2B—GPCR ligand binding—CCR5—Kawasaki disease	6.59e-05	0.00245	CbGpPWpGaD
Chlorpromazine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—Kawasaki disease	6.51e-05	0.00242	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—ITPKC—Kawasaki disease	6.48e-05	0.00241	CbGpPWpGaD
Chlorpromazine—ADRA2A—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	6.44e-05	0.00239	CbGpPWpGaD
Chlorpromazine—ALB—Platelet degranulation—VEGFA—Kawasaki disease	6.37e-05	0.00236	CbGpPWpGaD
Chlorpromazine—HRH4—Signaling by GPCR—CCR5—Kawasaki disease	6.23e-05	0.00231	CbGpPWpGaD
Chlorpromazine—DRD1—GPCR ligand binding—CCR5—Kawasaki disease	6.22e-05	0.00231	CbGpPWpGaD
Chlorpromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	6.16e-05	0.00229	CbGpPWpGaD
Chlorpromazine—DRD3—GPCR ligand binding—CCR5—Kawasaki disease	6.13e-05	0.00228	CbGpPWpGaD
Chlorpromazine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—Kawasaki disease	6.07e-05	0.00225	CbGpPWpGaD
Chlorpromazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	6.06e-05	0.00225	CbGpPWpGaD
Chlorpromazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	6.05e-05	0.00225	CbGpPWpGaD
Chlorpromazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	6.03e-05	0.00224	CbGpPWpGaD
Chlorpromazine—HTR1A—SIDS Susceptibility Pathways—VEGFA—Kawasaki disease	6.02e-05	0.00223	CbGpPWpGaD
Chlorpromazine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	6.01e-05	0.00223	CbGpPWpGaD
Chlorpromazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	5.95e-05	0.00221	CbGpPWpGaD
Chlorpromazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	5.94e-05	0.00221	CbGpPWpGaD
Chlorpromazine—CALM3—VEGFA-VEGFR2 Pathway—VEGFA—Kawasaki disease	5.83e-05	0.00217	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—ITPKC—Kawasaki disease	5.68e-05	0.00211	CbGpPWpGaD
Chlorpromazine—CALM2—VEGFA-VEGFR2 Pathway—VEGFA—Kawasaki disease	5.64e-05	0.0021	CbGpPWpGaD
Chlorpromazine—CALM1—VEGFA-VEGFR2 Pathway—VEGFA—Kawasaki disease	5.64e-05	0.0021	CbGpPWpGaD
Chlorpromazine—ABCB1—Allograft Rejection—VEGFA—Kawasaki disease	5.64e-05	0.00209	CbGpPWpGaD
Chlorpromazine—CALM3—Innate Immune System—FCGR2A—Kawasaki disease	5.52e-05	0.00205	CbGpPWpGaD
Chlorpromazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	5.52e-05	0.00205	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by VEGF—VEGFA—Kawasaki disease	5.51e-05	0.00205	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—ITPKC—Kawasaki disease	5.35e-05	0.00199	CbGpPWpGaD
Chlorpromazine—HTR1A—GPCR ligand binding—CCR5—Kawasaki disease	5.35e-05	0.00199	CbGpPWpGaD
Chlorpromazine—CALM1—Innate Immune System—FCGR2A—Kawasaki disease	5.34e-05	0.00198	CbGpPWpGaD
Chlorpromazine—CALM2—Innate Immune System—FCGR2A—Kawasaki disease	5.34e-05	0.00198	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by VEGF—VEGFA—Kawasaki disease	5.33e-05	0.00198	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by VEGF—VEGFA—Kawasaki disease	5.33e-05	0.00198	CbGpPWpGaD
Chlorpromazine—HTR2C—GPCR ligand binding—CCR5—Kawasaki disease	5.32e-05	0.00197	CbGpPWpGaD
Chlorpromazine—DRD5—GPCR downstream signaling—CCR5—Kawasaki disease	5.29e-05	0.00196	CbGpPWpGaD
Chlorpromazine—HTR2A—SIDS Susceptibility Pathways—VEGFA—Kawasaki disease	5.2e-05	0.00193	CbGpPWpGaD
Chlorpromazine—CALM3—Adaptive Immune System—BLK—Kawasaki disease	5.14e-05	0.00191	CbGpPWpGaD
Chlorpromazine—CHRM2—SIDS Susceptibility Pathways—VEGFA—Kawasaki disease	5.1e-05	0.0019	CbGpPWpGaD
Chlorpromazine—ADRA1B—GPCR ligand binding—CCR5—Kawasaki disease	5.09e-05	0.00189	CbGpPWpGaD
Chlorpromazine—CALM2—Adaptive Immune System—BLK—Kawasaki disease	4.98e-05	0.00185	CbGpPWpGaD
Chlorpromazine—CALM1—Adaptive Immune System—BLK—Kawasaki disease	4.98e-05	0.00185	CbGpPWpGaD
Chlorpromazine—DRD5—Signaling by GPCR—CCR5—Kawasaki disease	4.8e-05	0.00178	CbGpPWpGaD
Chlorpromazine—DRD2—GPCR ligand binding—CCR5—Kawasaki disease	4.69e-05	0.00174	CbGpPWpGaD
Chlorpromazine—HTR2A—GPCR ligand binding—CCR5—Kawasaki disease	4.62e-05	0.00171	CbGpPWpGaD
Chlorpromazine—HRH1—GPCR ligand binding—CCR5—Kawasaki disease	4.61e-05	0.00171	CbGpPWpGaD
Chlorpromazine—CHRM1—GPCR ligand binding—CCR5—Kawasaki disease	4.59e-05	0.00171	CbGpPWpGaD
Chlorpromazine—CHRM3—GPCR ligand binding—CCR5—Kawasaki disease	4.58e-05	0.0017	CbGpPWpGaD
Chlorpromazine—CHRM2—GPCR ligand binding—CCR5—Kawasaki disease	4.53e-05	0.00168	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—ITPKC—Kawasaki disease	4.53e-05	0.00168	CbGpPWpGaD
Chlorpromazine—ADRA1A—GPCR ligand binding—CCR5—Kawasaki disease	4.52e-05	0.00168	CbGpPWpGaD
Chlorpromazine—CALM3—Adaptive Immune System—CD40—Kawasaki disease	4.28e-05	0.00159	CbGpPWpGaD
Chlorpromazine—ADRA2A—GPCR ligand binding—CCR5—Kawasaki disease	4.2e-05	0.00156	CbGpPWpGaD
Chlorpromazine—CALM1—Adaptive Immune System—CD40—Kawasaki disease	4.14e-05	0.00154	CbGpPWpGaD
Chlorpromazine—CALM2—Adaptive Immune System—CD40—Kawasaki disease	4.14e-05	0.00154	CbGpPWpGaD
Chlorpromazine—HTR6—GPCR downstream signaling—CCR5—Kawasaki disease	4.08e-05	0.00152	CbGpPWpGaD
Chlorpromazine—HTR7—GPCR downstream signaling—CCR5—Kawasaki disease	4.08e-05	0.00151	CbGpPWpGaD
Chlorpromazine—DRD4—GPCR downstream signaling—CCR5—Kawasaki disease	3.9e-05	0.00145	CbGpPWpGaD
Chlorpromazine—HTR2B—GPCR downstream signaling—CCR5—Kawasaki disease	3.73e-05	0.00138	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling by GPCR—CCR5—Kawasaki disease	3.71e-05	0.00138	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling by GPCR—CCR5—Kawasaki disease	3.7e-05	0.00137	CbGpPWpGaD
Chlorpromazine—HRH4—Signaling Pathways—CCR5—Kawasaki disease	3.68e-05	0.00137	CbGpPWpGaD
Chlorpromazine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	3.58e-05	0.00133	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling by GPCR—CCR5—Kawasaki disease	3.54e-05	0.00132	CbGpPWpGaD
Chlorpromazine—DRD1—GPCR downstream signaling—CCR5—Kawasaki disease	3.51e-05	0.0013	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—ITPKC—Kawasaki disease	3.5e-05	0.0013	CbGpPWpGaD
Chlorpromazine—DRD3—GPCR downstream signaling—CCR5—Kawasaki disease	3.47e-05	0.00129	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling by GPCR—CCR5—Kawasaki disease	3.38e-05	0.00126	CbGpPWpGaD
Chlorpromazine—CALM3—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	3.27e-05	0.00121	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—FCGR2A—Kawasaki disease	3.22e-05	0.00119	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling by GPCR—CCR5—Kawasaki disease	3.19e-05	0.00118	CbGpPWpGaD
Chlorpromazine—CALM2—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	3.16e-05	0.00117	CbGpPWpGaD
Chlorpromazine—CALM1—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	3.16e-05	0.00117	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling by GPCR—CCR5—Kawasaki disease	3.15e-05	0.00117	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—BLK—Kawasaki disease	3.12e-05	0.00116	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—FCGR2A—Kawasaki disease	3.11e-05	0.00116	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—FCGR2A—Kawasaki disease	3.11e-05	0.00116	CbGpPWpGaD
Chlorpromazine—HTR1A—GPCR downstream signaling—CCR5—Kawasaki disease	3.02e-05	0.00112	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—BLK—Kawasaki disease	3.02e-05	0.00112	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—BLK—Kawasaki disease	3.02e-05	0.00112	CbGpPWpGaD
Chlorpromazine—HTR2C—GPCR downstream signaling—CCR5—Kawasaki disease	3.01e-05	0.00112	CbGpPWpGaD
Chlorpromazine—ADRA1B—GPCR downstream signaling—CCR5—Kawasaki disease	2.88e-05	0.00107	CbGpPWpGaD
Chlorpromazine—CALM3—Innate Immune System—CRP—Kawasaki disease	2.87e-05	0.00107	CbGpPWpGaD
Chlorpromazine—DRD5—Signaling Pathways—CCR5—Kawasaki disease	2.84e-05	0.00105	CbGpPWpGaD
Chlorpromazine—ALB—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	2.82e-05	0.00105	CbGpPWpGaD
Chlorpromazine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	2.78e-05	0.00103	CbGpPWpGaD
Chlorpromazine—CALM2—Innate Immune System—CRP—Kawasaki disease	2.78e-05	0.00103	CbGpPWpGaD
Chlorpromazine—CALM1—Innate Immune System—CRP—Kawasaki disease	2.78e-05	0.00103	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling by GPCR—CCR5—Kawasaki disease	2.74e-05	0.00102	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling by GPCR—CCR5—Kawasaki disease	2.73e-05	0.00101	CbGpPWpGaD
Chlorpromazine—DRD2—GPCR downstream signaling—CCR5—Kawasaki disease	2.65e-05	0.000985	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling by GPCR—CCR5—Kawasaki disease	2.61e-05	0.00097	CbGpPWpGaD
Chlorpromazine—HTR2A—GPCR downstream signaling—CCR5—Kawasaki disease	2.61e-05	0.000969	CbGpPWpGaD
Chlorpromazine—HRH1—GPCR downstream signaling—CCR5—Kawasaki disease	2.6e-05	0.000967	CbGpPWpGaD
Chlorpromazine—CHRM1—GPCR downstream signaling—CCR5—Kawasaki disease	2.6e-05	0.000964	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—CD40—Kawasaki disease	2.59e-05	0.000963	CbGpPWpGaD
Chlorpromazine—CHRM3—GPCR downstream signaling—CCR5—Kawasaki disease	2.59e-05	0.000961	CbGpPWpGaD
Chlorpromazine—CHRM2—GPCR downstream signaling—CCR5—Kawasaki disease	2.56e-05	0.000952	CbGpPWpGaD
Chlorpromazine—ADRA1A—GPCR downstream signaling—CCR5—Kawasaki disease	2.56e-05	0.000949	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—CD40—Kawasaki disease	2.51e-05	0.000932	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—CD40—Kawasaki disease	2.51e-05	0.000932	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling by GPCR—CCR5—Kawasaki disease	2.41e-05	0.000894	CbGpPWpGaD
Chlorpromazine—ADRA2A—GPCR downstream signaling—CCR5—Kawasaki disease	2.37e-05	0.000882	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling by GPCR—CCR5—Kawasaki disease	2.37e-05	0.00088	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling by GPCR—CCR5—Kawasaki disease	2.36e-05	0.000878	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling by GPCR—CCR5—Kawasaki disease	2.36e-05	0.000875	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling by GPCR—CCR5—Kawasaki disease	2.35e-05	0.000873	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling by GPCR—CCR5—Kawasaki disease	2.33e-05	0.000864	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling by GPCR—CCR5—Kawasaki disease	2.32e-05	0.000862	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—CCR5—Kawasaki disease	2.19e-05	0.000813	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—CCR5—Kawasaki disease	2.19e-05	0.000812	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling by GPCR—CCR5—Kawasaki disease	2.16e-05	0.000801	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—CCR5—Kawasaki disease	2.09e-05	0.000777	CbGpPWpGaD
Chlorpromazine—HRH4—Signaling Pathways—MMP9—Kawasaki disease	2.01e-05	0.000748	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—CCR5—Kawasaki disease	2e-05	0.000742	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—CCR5—Kawasaki disease	1.97e-05	0.000731	CbGpPWpGaD
Chlorpromazine—CALM3—Innate Immune System—CD4—Kawasaki disease	1.94e-05	0.00072	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—CCR5—Kawasaki disease	1.9e-05	0.000707	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—CCR5—Kawasaki disease	1.9e-05	0.000707	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—CCR5—Kawasaki disease	1.88e-05	0.0007	CbGpPWpGaD
Chlorpromazine—CALM2—Innate Immune System—CD4—Kawasaki disease	1.87e-05	0.000696	CbGpPWpGaD
Chlorpromazine—CALM1—Innate Immune System—CD4—Kawasaki disease	1.87e-05	0.000696	CbGpPWpGaD
Chlorpromazine—CALM3—Adaptive Immune System—CD4—Kawasaki disease	1.86e-05	0.000691	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—CCR5—Kawasaki disease	1.86e-05	0.000691	CbGpPWpGaD
Chlorpromazine—ADRA2A—Hemostasis—VEGFA—Kawasaki disease	1.84e-05	0.000685	CbGpPWpGaD
Chlorpromazine—HRH4—Signaling Pathways—VEGFA—Kawasaki disease	1.81e-05	0.000671	CbGpPWpGaD
Chlorpromazine—CALM1—Adaptive Immune System—CD4—Kawasaki disease	1.8e-05	0.000669	CbGpPWpGaD
Chlorpromazine—CALM2—Adaptive Immune System—CD4—Kawasaki disease	1.8e-05	0.000669	CbGpPWpGaD
Chlorpromazine—CALM3—Hemostasis—VEGFA—Kawasaki disease	1.68e-05	0.000625	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—CRP—Kawasaki disease	1.67e-05	0.000621	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—CCR5—Kawasaki disease	1.66e-05	0.000616	CbGpPWpGaD
Chlorpromazine—CALM2—Hemostasis—VEGFA—Kawasaki disease	1.63e-05	0.000605	CbGpPWpGaD
Chlorpromazine—CALM1—Hemostasis—VEGFA—Kawasaki disease	1.63e-05	0.000605	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—CCR5—Kawasaki disease	1.62e-05	0.000602	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—CRP—Kawasaki disease	1.62e-05	0.0006	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—CRP—Kawasaki disease	1.62e-05	0.0006	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—CCR5—Kawasaki disease	1.61e-05	0.000599	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—CCR5—Kawasaki disease	1.61e-05	0.000596	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—CCR5—Kawasaki disease	1.61e-05	0.000596	CbGpPWpGaD
Chlorpromazine—DRD5—Signaling Pathways—MMP9—Kawasaki disease	1.55e-05	0.000576	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—CCR5—Kawasaki disease	1.54e-05	0.000573	CbGpPWpGaD
Chlorpromazine—ALB—Hemostasis—VEGFA—Kawasaki disease	1.46e-05	0.000541	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—CCR5—Kawasaki disease	1.42e-05	0.000528	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—CCR5—Kawasaki disease	1.4e-05	0.00052	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—CCR5—Kawasaki disease	1.4e-05	0.000519	CbGpPWpGaD
Chlorpromazine—DRD5—Signaling Pathways—VEGFA—Kawasaki disease	1.39e-05	0.000517	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—CCR5—Kawasaki disease	1.39e-05	0.000517	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—CCR5—Kawasaki disease	1.39e-05	0.000515	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—CCR5—Kawasaki disease	1.37e-05	0.00051	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—CCR5—Kawasaki disease	1.37e-05	0.000509	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—CCR5—Kawasaki disease	1.27e-05	0.000473	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—MMP9—Kawasaki disease	1.2e-05	0.000445	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—MMP9—Kawasaki disease	1.2e-05	0.000444	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CCR5—Kawasaki disease	1.16e-05	0.000432	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—MMP9—Kawasaki disease	1.14e-05	0.000425	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—CD4—Kawasaki disease	1.13e-05	0.000419	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CCR5—Kawasaki disease	1.12e-05	0.000417	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CCR5—Kawasaki disease	1.12e-05	0.000417	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—MMP9—Kawasaki disease	1.09e-05	0.000406	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—CD4—Kawasaki disease	1.09e-05	0.000405	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—CD4—Kawasaki disease	1.09e-05	0.000405	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—VEGFA—Kawasaki disease	1.08e-05	0.000399	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—VEGFA—Kawasaki disease	1.07e-05	0.000399	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—CD4—Kawasaki disease	1.04e-05	0.000387	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—MMP9—Kawasaki disease	1.03e-05	0.000383	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—VEGFA—Kawasaki disease	1.03e-05	0.000382	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—MMP9—Kawasaki disease	1.02e-05	0.000378	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—CD4—Kawasaki disease	1.01e-05	0.000374	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—CD4—Kawasaki disease	1.01e-05	0.000374	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—VEGFA—Kawasaki disease	9.81e-06	0.000364	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—VEGFA—Kawasaki disease	9.25e-06	0.000344	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—VEGFA—Kawasaki disease	9.13e-06	0.000339	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—MMP9—Kawasaki disease	8.86e-06	0.000329	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—MMP9—Kawasaki disease	8.82e-06	0.000327	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—MMP9—Kawasaki disease	8.44e-06	0.000313	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—VEGFA—Kawasaki disease	7.96e-06	0.000296	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—VEGFA—Kawasaki disease	7.92e-06	0.000294	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—MMP9—Kawasaki disease	7.78e-06	0.000289	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—MMP9—Kawasaki disease	7.66e-06	0.000284	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—MMP9—Kawasaki disease	7.64e-06	0.000284	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—MMP9—Kawasaki disease	7.62e-06	0.000283	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—MMP9—Kawasaki disease	7.59e-06	0.000282	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—VEGFA—Kawasaki disease	7.58e-06	0.000281	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—MMP9—Kawasaki disease	7.52e-06	0.000279	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—MMP9—Kawasaki disease	7.5e-06	0.000278	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—VEGFA—Kawasaki disease	6.99e-06	0.000259	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—MMP9—Kawasaki disease	6.97e-06	0.000259	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—VEGFA—Kawasaki disease	6.87e-06	0.000255	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—VEGFA—Kawasaki disease	6.86e-06	0.000255	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—VEGFA—Kawasaki disease	6.84e-06	0.000254	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—VEGFA—Kawasaki disease	6.82e-06	0.000253	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—VEGFA—Kawasaki disease	6.75e-06	0.000251	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—VEGFA—Kawasaki disease	6.73e-06	0.00025	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—MMP9—Kawasaki disease	6.36e-06	0.000236	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—VEGFA—Kawasaki disease	6.25e-06	0.000232	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—MMP9—Kawasaki disease	6.15e-06	0.000228	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—MMP9—Kawasaki disease	6.15e-06	0.000228	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—VEGFA—Kawasaki disease	5.71e-06	0.000212	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—VEGFA—Kawasaki disease	5.52e-06	0.000205	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—VEGFA—Kawasaki disease	5.52e-06	0.000205	CbGpPWpGaD
